Dabur Limited’s stock experienced a sharp decline with heavy trading volumes on October 19 following its disclosure on October 18 regarding ongoing litigations involving its three US subsidiaries. The litigations are in their early discovery phases and pertain to allegations that a hair-relaxer product may contain chemicals linked to ovarian cancer, uterine cancer, and other health concerns. These cases have been filed in federal and state courts in the US and Canada, with the federal US cases consolidated as a Multi-District Litigation (MDL).
Dabur’s subsidiaries, namely Namaste, Dermoviva, and DINTL, have denied any responsibility and enlisted legal representation to defend themselves against these lawsuits. The defense argument centers on the claim that the allegations rely on an incomplete and unverified study.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
